November 18, 2016, as a leading supplier and manufacturer in life science and biotechnology, Creative Bioarray decided to allocate millions to develop its bone marrow cells product line in order to meet all kinds of demands from the market.
Bone marrow cells are the cells existing in the bone marrow. These include stromal cells, which are not directly contained in haematopoiesis and haematopoietic stem cells. When the development of normal blood cell is interrupted by uncontrolled growth of an abnormal type of blood cell, the blood cancer begins. In Creative Bioarray, there are all kinds of normal bone marrow cells, including bone marrow stromal cells, human bone marrow cells and so on.
Bone marrow mononuclear cells Recently, bone marrow mononuclear cells have been in the spotlight for having the potential to treat various diseases, such as neurological disorders. And BMMC also have regenerative capabilities and are a heterogeneous population od single nucleus cells. What’s more, bone marrow mononuclear cells also used for bone tissue engineering. And having show great potential as a cell therapy in humans, they have been shown to be reasonably safe.
Human bone marrow cells Referring to human bone marrow cells, its application in analyzing the release of haemopoietic growth factors at the single cell level. Usually, researchers adopt the reverse haemolytic plaque assay. Human marrow cells isolated were detected for the release of interleukin-1a (IL-1a), IL-3, IL-6 and granulocyte-monocyte colony stimulating factor (GM-CSF).
“allocating millions to develop and improve our bone marrow cells product line is a long-term plan for Creative Bioarray. Considering the great demand from this market, scientists in Creative Bioarray decided to develop more related cell product in order to meet customers’ needs. I also believe that this plan will gain great success.” said Dr. Herrenknecht, senior officer in Creative Bioarray.
Bone marrow cells play very crucial roles in some diseases researches and treatment. Developing this line will be a promising project for biotech companies.
